Free Trial

Brokers Set Expectations for Ascend Wellness FY2029 Earnings

Ascend Wellness logo with Medical background
Remove Ads

Ascend Wellness Holdings, Inc. (OTC:AAWH - Free Report) - Stock analysts at Atb Cap Markets issued their FY2029 EPS estimates for Ascend Wellness in a report released on Thursday, March 13th. Atb Cap Markets analyst F. Gomes anticipates that the company will earn ($0.10) per share for the year. The consensus estimate for Ascend Wellness' current full-year earnings is ($0.40) per share.

Ascend Wellness Stock Down 2.8 %

Shares of AAWH traded down $0.01 on Friday, reaching $0.35. The company's stock had a trading volume of 5,759 shares, compared to its average volume of 125,517. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61. Ascend Wellness has a twelve month low of $0.27 and a twelve month high of $1.55. The stock has a market capitalization of $75.05 million, a PE ratio of -0.85 and a beta of 1.27. The firm has a fifty day moving average of $0.37 and a 200-day moving average of $0.56.

About Ascend Wellness

(Get Free Report)

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.

Featured Stories

Earnings History and Estimates for Ascend Wellness (OTC:AAWH)

Should You Invest $1,000 in Ascend Wellness Right Now?

Before you consider Ascend Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.

While Ascend Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads